登革熱檢測市場規模、佔有率和成長分析：按診斷技術、產品類型、檢體類型、服務模式、最終用戶和地區分類－2026-2033年產業預測

2024 年全球登革熱檢測市場價值為 6.8906 億美元，預計到 2025 年將成長至 7.2565 億美元，到 2033 年將成長至 10.977 億美元，在預測期（2026-2033 年）內複合年成長率為 5.31%。

登革熱檢測市場受到都市化和氣候變遷的嚴重影響，這兩者加劇了人口密集地區的感染傳播。這種情況給醫療衛生系統帶來了沉重負擔，各國政府正大力推動採用先進的診斷解決方案，以便快速確診病例並採取有效的應對措施。雅培和羅氏等公司正在推出可與智慧型手機應用程式整合的攜帶式免疫檢測設備，吸引了旨在控制疫情的資助機構的注意。新興經濟體可支配收入的成長和保險覆蓋範圍的擴大，正推動檢測網路的進一步擴展，從而促進收入成長並加強疾病監測系統。此外，人工智慧驅動的自動化技術在登革熱診斷中的應用，透過最佳化檢測流程、簡化檢體處理和提高準確性，提高了效率，使最先進的檢測解決方案成為對抗疾病和快速反應的關鍵要素。

全球登革熱檢測市場促進因素

全球城市人口的快速成長導致人口過度擁擠，為埃及斑蚊的滋生提供了有利條件，進而導致登革熱發病率上升。疾病發生率的上升迫使醫療機構和相關部門採取快速診斷措施，以有效識別和控制病例。因此，對可靠的檢測套組的需求日益成長。這些試劑盒對於醫院、實驗室和公共衛生部門至關重要，因為它們需要快速且準確的檢測結果來改善患者照護並遏制新興市場感染的傳播。此外，公眾意識的提高也鼓勵社區採取積極主動的檢測策略。

全球登革熱檢測市場面臨的限制因素

先進的登革熱診斷試劑盒高成本，為醫療服務提供者帶來了巨大障礙，尤其是在登革熱流行且預算有限的低收入地區。財政限制迫使醫院和公共衛生機構全面評估成本效益，往往導致他們選擇價格更低、技術要求較低的檢測方案。這種價格挑戰阻礙了創新技術的市場准入，抑制了需求成長，並迫使製造商在提升產品性能和降低價格之間尋求平衡，以提高產品的可及性。因此，這些因素限制了登革熱檢測市場的潛在發展。

全球登革熱檢測市場趨勢

全球登革熱檢測市場正呈現出顯著的趨勢，即時檢測解決方案的快速發展，這主要得益於分散式醫療保健需求的日益成長。這種轉變推動了對快速、攜帶式登革熱診斷工具的需求，這些工具可在診所、學校和社區健康中心等多種場所使用。製造商正不斷將使用者友好的介面整合到電池供電的平台中，使即使是培訓不足的工作人員也能快速獲得可靠的檢測結果。這些進步不僅減少了對中心檢查室的依賴，也縮短了病患分流時間，並有助於在偏遠流行地區進行有效的集體爆發監測，從而使即時檢測解決方案成為市場成長的關鍵驅動力。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球登革熱檢測市場規模：依診斷技術分類

• NS1抗原檢測
• IgM 和 IgG 血清學 ELISA
• RT-PCR分子檢測
• 聯合檢驗和麵板檢驗
• 利用新型生物感測器的測試方法

全球登革熱檢測市場規模：依產品類型分類

• 快速診斷試劑盒
• ELISA試劑盒和試劑
• PCR分子檢測套組

全球登革熱檢測市場規模：依樣本類型分類

• 血清和血漿
• 全血
  • 指尖採血
  • 靜脈血
• 唾液和口腔液
• 其他

全球登革熱檢測市場規模：依服務類型分類

• 集中測試
• 即時檢測

全球登革熱檢測市場規模：依最終用戶分類

• 醫院和診所
• 診斷檢查室
• 居家照護和自我檢測中心
• 公共衛生和監測機構
• 其他

全球登革熱檢測市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories Inc.
• Becton Dickinson and Company
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Qiagen NV
• Eurofins Scientific SE
• Standard Diagnostics Inc.
• Ortho Clinical Diagnostics Inc.
• BioMerieux SA
• Nova Biologicals Inc.
• DiaSorin SpA
• QuidelOrtho Corporation
• Artron Laboratories Inc.
• CTK Biotech Inc.
• Creative Diagnostics
• InBios International Inc.
• GeneReach Biotechnology Corp.
• SD Biosensor Inc.

結論與建議

Global Dengue Testing Market size was valued at USD 689.06 Million in 2024 and is poised to grow from USD 725.65 Million in 2025 to USD 1097.7 Million by 2033, growing at a CAGR of 5.31% during the forecast period (2026-2033).

The dengue testing market is significantly influenced by urbanization and climate change, which contribute to increased transmission in densely populated areas. This scenario places immense pressure on healthcare systems, prompting governments to embrace advanced diagnostic solutions for quicker case confirmation and effective control measures. Companies like Abbott and Roche have introduced portable immunoassay devices integrated with smartphone applications, driving interest from funding organizations aiming to mitigate outbreaks. The rise in disposable incomes and enhanced insurance coverage in emerging economies further expands laboratory networks, enabling revenue growth and better disease surveillance. Additionally, the integration of AI-driven automation in dengue diagnostics enhances efficiency by optimizing assay processes, streamlining sample handling, and improving accuracy, positioning modern testing solutions as integral in combating the disease and ensuring timely responses.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dengue Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dengue Testing Market Segments Analysis

Global dengue testing market is segmented by diagnostic technology, product type, sample type, service modality, end-user and region. Based on diagnostic technology, the market is segmented into NS1 Antigen Tests, IgM and IgG Serology ELISA, RT-PCR Molecular Tests, Combination and Panel Assays and Novel Biosensor-Based Tests. Based on product type, the market is segmented into Rapid Diagnostic Test Kits, ELISA Kits and Reagents and PCR Molecular Assay Kits. Based on sample type, the market is segmented into Serum and Plasma, Whole Blood, Saliva and Oral Fluid and Others. Based on service modality, the market is segmented into Centralized Laboratory Testing and Point-of-Care Testing. Based on end-user, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Home Care and Self-Testing Centres, Public Health and Surveillance Agencies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dengue Testing Market

The global surge in urban populations leads to crowded environments that are conducive to the proliferation of Aedes mosquitoes, resulting in a higher prevalence of dengue infections. This increased disease incidence compels healthcare providers and authorities to implement swift diagnostic measures for effective case identification and management. As a result, there is a growing demand for dependable testing kits, which are essential for hospitals, laboratories, and public health initiatives striving for rapid and accurate results that enhance patient care and assist in controlling outbreaks in emerging markets. Additionally, elevated public awareness encourages communities to adopt proactive testing strategies.

Restraints in the Global Dengue Testing Market

The elevated costs linked to advanced dengue diagnostic kits present a notable obstacle for healthcare providers, especially in low-income areas where dengue is prevalent and budgets are limited. Financial constraints require hospitals and public health initiatives to thoroughly assess cost-effectiveness, frequently resulting in the adoption of cheaper, less advanced testing options. This pricing challenge hampers the market entry of innovative technologies, stifles demand growth, and drives manufacturers to find a balance between enhancing performance and reducing prices to make their products more accessible. Consequently, this dynamic limits the potential advancements within the dengue testing market.

Market Trends of the Global Dengue Testing Market

The global dengue testing market is witnessing a significant trend towards the expansion of point-of-care testing solutions, driven by the growing need for decentralized healthcare. This shift has spurred demand for rapid and portable dengue diagnostic tools that can be utilized in various settings, such as clinics, schools, and community health posts. Manufacturers are increasingly integrating battery-operated platforms with user-friendly interfaces, enabling minimally trained personnel to deliver reliable results swiftly. Such advancements not only reduce dependence on central laboratories, but also enhance patient triage times and facilitate effective outbreak surveillance in remote endemic regions, establishing point-of-care solutions as a vital component of market growth.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Dengue Testing Market Size by Diagnostic Technology & CAGR (2026-2033)

• Market Overview
• NS1 Antigen Tests
• IgM and IgG Serology ELISA
• RT-PCR Molecular Tests
• Combination and Panel Assays
• Novel Biosensor-Based Tests

Global Dengue Testing Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Rapid Diagnostic Test Kits
• ELISA Kits and Reagents
• PCR Molecular Assay Kits

Global Dengue Testing Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Serum and Plasma
• Whole Blood
  • Finger-Stick
  • Venous Blood
• Saliva and Oral Fluid
• Others

Global Dengue Testing Market Size by Service Modality & CAGR (2026-2033)

• Market Overview
• Centralized Laboratory Testing
• Point-of-Care Testing

Global Dengue Testing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care and Self-Testing Centres
• Public Health and Surveillance Agencies
• Others

Global Dengue Testing Market Size & CAGR (2026-2033)

• North America (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
  • US
  • Canada
• Europe (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard Diagnostics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biologicals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artron Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTK Biotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InBios International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneReach Biotechnology Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations